The Health Resources and Services Administration is reminding hospitals that participate in the 340B drug savings program that they must recertify by Dec. 6 or they will be terminated from the program. HRSA is required to recertify annually all participating covered entities enrolled in the 340B program to ensure they are appropriately listed on the 340B database and that covered entities remain compliant with the 340B program requirements. This year, HRSA unveiled a new recertification process, and any hospital that recertified or started the recertification process before Nov. 3 must complete a new recertification by Dec. 6. For questions about the recertification process, please visit https://www.hrsa.gov/opa/340b-opais/index.html or contact the 340B Prime Vendor Program at (888) 340-2787 or at apexusanswers@340pvp.com

Headline
The House Energy and Commerce Subcommittee on Health held a hearing Sept. 15 to discuss more than a dozen legislative proposals regarding Medicare provider…
Headline
As policymakers continue to discuss healthcare legislation, the AHA has developed several new resources to help hospitals and other stakeholders understand the…
Headline
The AHA Aug. 31 joined a coalition led by LeadingAge and other national healthcare organizations in submitting comments to the Centers for Medicare &…
Headline
The Centers for Medicare & Medicaid Services has released a fact sheet and FAQs on the 340B Part D claims data repository that will go live Oct. 1. Data…
Headline
The AHA Aug. 26 urged the Centers for Medicare & Medicaid Services not to finalize two proposals in the calendar year 2027 outpatient prospective payment…
Headline
The AHA Aug. 25 submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act),…